A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Clinical trial NCT01352793 · COMPLETED

Trial details

NCT number: NCT01352793
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningitis, Meningococcal

Start date: 2012-11-01
Primary completion: 2014-09-01
Enrollment: 5715

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.